机译:乳腺癌患者不良事件的动态画像:艾日布林治疗晚期 HER2 阴性乳腺癌的 II 期临床试验结果
Dana Farber Canc Inst, Boston, MA 02115 USA;
Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA;
Eastern Maine Med Ctr, Bangor, ME USAIndiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA;
Breast cancer; Eribulin; Adverse event; CTCAE; PRO-CTCAE;